Barclays Maintains Underweight on BrightSpire Capital, Lowers Price Target to $4

Benzinga Newsdesk www.benzinga.com Negative 92.6%

Neg 92.6% Neu 0% Pos 0%

Barclays analyst Terry Ma maintains BrightSpire Capital (NYSE:BRSP) with a Underweight and lowers the price target from $6 to $4.